“…Given the intriguing structures and the medicinal importance of polycyclic indole-based molecules [ 1 , 2 , 3 , 4 , 5 , 6 , 7 ], we envisioned that the amalgamation of the indole moiety [ 8 , 9 , 10 , 11 , 12 , 13 ] with the pyridazine ring [ 14 , 15 , 16 , 17 , 18 , 19 ] that potentially generates different isomeric scaffolds ( a – c ) would lead to entities endowed with either amplified or new biological activities ( Figure 1 ). A large number of reports dedicated to the synthesis of these appealing frameworks and studies on their pharmacologic activities appeared in the literature in the past few decades [ 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ].…”